The role of stem cell markers in multidrug resistance mediated by ABC transporters

Leukemia Research

Volumn 34, Issue 6, 2010, Pages 696-697

  Tiwari, Amit K ^a   An, Xin ^a,b   Chen, Zhe Sheng ^a  

^a ST JOHN'S UNIVERSITY   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER G1; BIOLOGICAL MARKER; BREAST CANCER RESISTANCE PROTEIN; CD34 ANTIGEN; CD38 ANTIGEN; E1A PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; STEM CELL FACTOR; TRANSCRIPTION FACTOR SOX2;

APOPTOSIS; CELL CYCLE G0 PHASE; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; DIMERIZATION; DNA REPAIR; DOWN REGULATION; EDITORIAL; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING;

ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; K562 CELLS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; TUMOR MARKERS, BIOLOGICAL;

EID: 77952095078     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.12.007     Document Type: Editorial

References (15)

1. Marques D.S., Sandrini J.Z., Boyle R.T., Marins L.F., Trindade G.S. Relationships between multidrug resistance (MDR) and stem cell markers in human Chronic Myeloid Leukemia cell lines. Leukemia Res 2010, 34:757-762.
2. Lobo N.A., Shimono Y., Qian D., Clarke M.F. The biology of cancer stem cells. Annu Rev Cell Dev Biol 2007, 23:675-699.
3. Wicha M.S., Liu S., Dontu G. Cancer stem cells: an old idea-a paradigm shift. Cancer Res 2006, 66:1883-1890. discussion 1895-1886.
4. Zhang M., Rosen J.M. Stem cells in the etiology and treatment of cancer. Curr Opin Genet Dev 2006, 16:60-64.
5. Dean M., Fojo T., Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005, 5:275-284.
6. Raaijmakers M.H. ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia. Leukemia 2007, 21:2094-2102.
7. Patrawala L., Calhoun T., Schneider-Broussard R., Zhou J., Claypool K., Tang D.G. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 2005, 65:6207-6219.
8. Zhou S., Morris J.J., Barnes Y., Lan L., Schuetz J.D., Sorrentino B.P. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc Natl Acad Sci USA 2002, 99:12339-12344.
9. Bunting K.D. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 2002, 20:11-20.
10. Huang S., Terstappen L.W. Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38-hematopoietic stem cells. Blood 1994, 83:1515-1526.
11. Chen X., Vega V.B., Ng H.H. Transcriptional regulatory networks in embryonic stem cells. Cold Spring Harb Symp Quant Biol 2008, 73:203-209.
12. Raaijmakers M.H., Scadden D.T. Evolving concepts on the microenvironmental niche for hematopoietic stem cells. Curr Opin Hematol 2008, 15:301-306.
13. Jordanides N.E., Jorgensen H.G., Holyoake T.L., Mountford J.C. Functional ABCG2 is overexpressed on primary CML CD34+ cells and is inhibited by imatinib mesylate. Blood 2006, 108:1370-1373.
14. Pesce M., Scholer H.R. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 2001, 19:271-278.
15. Tai M.H., Chang C.C., Kiupel M., Webster J.D., Olson L.K., Trosko J.E. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005, 26:495-502.